AI assistant
Sending…
PERRIGO Co plc — Director's Dealing 2016
Mar 1, 2016
31387_dirs_2016-03-01_abf33de6-90e6-41d1-b464-d9532d5fcdfd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PERRIGO Co plc (PRGO)
CIK: 0001585364
Period of Report: 2016-02-26
Reporting Person: Needham Jeffrey (EVP, GM Consumer Healthcare)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-26 | Restricted Stock Units | $ | A | 1346 | Acquired | 2019-02-26 | Ordinary Shares (1346.0) | Direct |
| 2016-02-26 | Employee Stock Option Right to Buy | $129.23 | A | 7636 | Acquired | 2026-02-26 | Ordinary Shares (7636.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 7340 | Direct |
Footnotes
F1: Each Restricted Stock Unit represents a contingent right to receive one ordinary share of Perrigo Company plc.
F2: Restricted Stock Units awarded for capacity as Executive Vice President, pursuant to the 2013 Long-term Incentive Plan.
F3: Exercisable in 3 equal annual installments beginning 2/26/2017.
More from PERRIGO Co plc
Earnings Release
2026
May 6
Regulatory Filings
2026
May 5
Transaction in Own Shares
2026
May 5
Share Issue/Capital Change
2026
May 5
Share Issue/Capital Change
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20